Determinants of AAV Lung Tropism
Determinants of AAV Lung Tropism
批准号:
8386661
负责人:
Aravind Asokan
金额:
$27.9万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-12 至 2013-12-31
关键词:
Amino AcidsAnimalsAvian Influenza A VirusBackBindingBiochemicalBiologicalCapsidCell LineCell PolarityCell surfaceCellsClinical ResearchCollaborationsComparative BiologyCystic FibrosisDNADNA ShufflingDependovirusDiseaseElementsEmployee StrikesEpithelial CellsGenerationsGlycoproteinsGoalsHumanIn VitroIntegrinsKnowledgeLibrariesLungLung diseasesMapsMediatingMolecularMolecular VirologyMusMutagenesisPoint MutationPolysaccharidesReagentRespiratory SystemRespiratory tract structureRoleSARS coronavirusSerotypingTechniquesTropismUpdateVariantadeno-associated viral vectorairway epitheliumcell typecombinatorialdesigndirected evolutiongene therapyin vitro Modelin vivoinfluenzavirusinsightnovelparainfluenza viruspathogenpre-clinicalpreferencereceptortransduction efficiencyvirus tropism
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Respiratory tract pathogens such as the human parainfluenza virus and SARS coronavirus effectively
infect human airways by exploiting a diverse set of cell surface glycans and glycoprotein receptors
encountered in airway cell types. In case of adeno-associated viruses (AAV), serotypes 1, 5, 6 and more
recently, AAV9 have been shown to efficiently transduce airways in vitro and in vivo, albeit with striking
species-specific and serotype-specific differences. The goal of this proposal is to elucidate molecular and
cellular determinants of airway tropism in AAV serotypes. To achieve such, we have devised a comprehensive
approach that hinges on molecular manipulation of AAV capsids through mutagenesis, biochemical reagents
for identification of glycans and co-receptors that mediate AAV airway cell entry and relevant in vitro models of
the human respiratory tract. The strategies described herein will (a) define AAV capsid structural elements at
the amino acid level that determine airway tropism, and (b) enable identification of cell surface components
including glycans and integrin subunits that dictate AAV tropism for different airway cell types. The proposed
studies will help provide a comprehensive picture of the mechanisms underlying AAV airway cell entry as well
as provide insight into species-specific differences in AAV airway tropism. If successful, this knowledge may
facilitate improvements in AAV vectors as well as in the design of preclinical/clinical studies focused on gene
therapy of airway diseases such as cystic fibrosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting AAV silencing in humanized mice
-
批准号:10562376
-
项目类别:
-
资助金额:$61.62万
-
财政年份:2023
-
负责人:Aravind Asokan
-
依托单位:
Engineering the biology of AAV secretion and production
-
批准号:10656028
-
项目类别:
-
资助金额:$45.7万
-
财政年份:2023
-
负责人:Aravind Asokan
-
依托单位:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
-
批准号:10640060
-
项目类别:
-
资助金额:$97.19万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
-
批准号:10667569
-
项目类别:
-
资助金额:$47.71万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
-
批准号:10480356
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
-
批准号:10371617
-
项目类别:
-
资助金额:$98.54万
-
财政年份:2022
-
负责人:Aravind Asokan
-
依托单位:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
-
批准号:10482406
-
项目类别:
-
资助金额:$115.87万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
RE-ENGINEERING AAV GENOME PACKAGING
-
批准号:9919589
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
-
批准号:10465740
-
项目类别:
-
资助金额:$83.36万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
CircRNAs and CNS Gene Transfer
-
批准号:9898485
-
项目类别:
-
资助金额:$37.58万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
CircRNAs and CNS Gene Transfer
-
批准号:10158515
-
项目类别:
-
资助金额:$37.57万
-
财政年份:2018
-
负责人:Aravind Asokan
-
依托单位:
Neutralizing Antibody & AAV FIX Gene Therapy
-
批准号:8990027
-
项目类别:
-
资助金额:$230.58万
-
财政年份:2013
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7822438
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2009
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7871991
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2009
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7583075
-
项目类别:
-
资助金额:$29.54万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:7749567
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Lung Tropism
-
批准号:8197206
-
项目类别:
-
资助金额:$29.3万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:8785694
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:10198986
-
项目类别:
-
资助金额:$62.82万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
Determinants of AAV Tropism
-
批准号:8577188
-
项目类别:
-
资助金额:$38.46万
-
财政年份:2008
-
负责人:Aravind Asokan
-
依托单位:
海外基金